Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Molecular Cancer Therapeutics|February 22, 2013
Tandutinib inhibits the Akt/mTOR signaling pathway to inhibit colon cancer growthSivapriya Ponnurangam, David Standing, Parthasarathy Rangarajan, et al.
Hepatic Medicine : Evidence and Research|December 8, 2025
Ischemia Reperfusion Injury Induced Systemic Inflammatory Response Following Interspecies Liver TransplantationJoseph Sushil Rao, Parthasarathy Rangarajan, Anala Shetty, et al.
Oncotarget|August 29, 2015
Crocetinic acid inhibits hedgehog signaling to inhibit pancreatic cancer stem cellsParthasarathy Rangarajan, Dharmalingam Subramaniam, Santanu Paul, et al.
Science Advances|January 7, 2026
Allospecific splenic Tr1 cells drive effector T cell exhaustion through up-regulated Areg-EGFR signaling to promote transplant toleranceAmar Singh, Adam Herman, Devanjan Dey, et al.
Science Advances|January 5, 2024
A bioengineered artificial interstitium supports long-term islet xenograft survival in nonhuman primates without immunosuppressionScott H Oppler, Laura L Hocum Stone, David J Leishman, et al.
Cell Death & Disease|June 1, 2021
Fosciclopirox suppresses growth of high-grade urothelial cancer by targeting the γ-secretase complexScott J Weir, Prasad Dandawate, David Standing, et al.
Cells|May 16, 2023
Establishment of Skeletal Myogenic Progenitors from Non-Human Primate Induced Pluripotent Stem CellsJune Baik, Carolina Ortiz-Cordero, Alessandro Magli, et al.
Biorxiv : the Preprint Server for Biology|May 7, 2026
Clinical-grade cryopreservation unlocks transplant-ready human pancreatic and stem cell-derived islets for diabetes therapyJoseph Sushil Rao, Zongqi Guo, Zenith Khashim, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 19, 2025
Preclinical quality, safety, and efficacy of a CGMP iPSC-derived myogenic progenitor product for the treatment of muscular dystrophiesKarim Azzag, Alessandro Magli, James Kiley, et al.
Pageof 1